Search research articles
Contact Us
Filters
Showing results (141-150 of 155) with videos related to
Page
of 16
Sort By:
Cancer Causes & Control : CCC
|
May 13, 2022
Factors associated with changes in exercise behaviors during the COVID-19 pandemic
Caroline Himbert, Cassandra A Hathaway, Bailee Daniels, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association
|
March 4, 2022
Impact of the COVID-19 pandemic on rural and urban cancer patients' experiences, health behaviors, and perceptions
Anita R Peoples, Laura B Oswald, Jennifer Ose, et al.
Science Translational Medicine
|
March 11, 2021
A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma
Priya Kumthekar, Caroline H Ko, Tatjana Paunesku, et al.
Acta Neuropathologica
|
October 22, 2022
Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1
Patrick J Cimino, Courtney Ketchum, Rust Turakulov, et al.
Biomolecules
|
November 11, 2022
Replicative Instability Drives Cancer Progression
Benjamin B Morris, Jason P Smith, Qi Zhang, et al.
Nature Medicine
|
February 12, 2019
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
Timothy F Cloughesy, Aaron Y Mochizuki, Joey R Orpilla, et al.
Nature Medicine
|
July 21, 2025
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Farshad Nassiri, Vikas Patil, Leeor S Yefet, et al.
Nature Medicine
|
May 15, 2023
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Farshad Nassiri, Vikas Patil, Leeor S Yefet, et al.
Journal of Behavioral Medicine
|
February 28, 2024
Risk factors and health behaviors associated with loneliness among cancer survivors during the COVID-19 pandemic
Elena S Aßmann, Jennifer Ose, Cassandra A Hathaway, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 22, 2026
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data
Tulika Rudra Gupta, Mei-Yin C Polley, Robert Redd, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 155) with videos related to
Sort By:
Page
of 16
Cancer Causes & Control : CCC
|
May 13, 2022
Factors associated with changes in exercise behaviors during the COVID-19 pandemic
Caroline Himbert, Cassandra A Hathaway, Bailee Daniels, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association
|
March 4, 2022
Impact of the COVID-19 pandemic on rural and urban cancer patients' experiences, health behaviors, and perceptions
Anita R Peoples, Laura B Oswald, Jennifer Ose, et al.
Science Translational Medicine
|
March 11, 2021
A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma
Priya Kumthekar, Caroline H Ko, Tatjana Paunesku, et al.
Acta Neuropathologica
|
October 22, 2022
Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1
Patrick J Cimino, Courtney Ketchum, Rust Turakulov, et al.
Biomolecules
|
November 11, 2022
Replicative Instability Drives Cancer Progression
Benjamin B Morris, Jason P Smith, Qi Zhang, et al.
Nature Medicine
|
February 12, 2019
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
Timothy F Cloughesy, Aaron Y Mochizuki, Joey R Orpilla, et al.
Nature Medicine
|
July 21, 2025
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Farshad Nassiri, Vikas Patil, Leeor S Yefet, et al.
Nature Medicine
|
May 15, 2023
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Farshad Nassiri, Vikas Patil, Leeor S Yefet, et al.
Journal of Behavioral Medicine
|
February 28, 2024
Risk factors and health behaviors associated with loneliness among cancer survivors during the COVID-19 pandemic
Elena S Aßmann, Jennifer Ose, Cassandra A Hathaway, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 22, 2026
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data
Tulika Rudra Gupta, Mei-Yin C Polley, Robert Redd, et al.
Page
of 16